Center for Scientific Review; Notice of Closed Meetings, 66947-66948 [2013-26623]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
Due to the absence of either an FY
2014 appropriation or Continuing
Resolution for the Department of Health
and Human Services, the meeting is
rescheduled for December 3, 2013 from
8:00 a.m. to 11:00 a.m. The meeting
location remains the same. The meeting
is closed to the public.
Dated: November 1, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26627 Filed 11–6–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel ZRG1
MDCN–C (58), October 18, 2013, 08:00
a.m. to October 18, 2013, 05:00 p.m.,
Pier 5 Hotel, 711 Eastern Avenue,
Baltimore, MD, 21202 which was
published in the Federal Register on
September 25, 2013, 78 FR 186 Pgs.
59040–59041.
The meeting will be held at the
Crowne Plaza Tyson Corner, 1960 Chain
Bridge Rd., McLean, VA 22102. The
meeting will start on November 19, 2013
at 8:00 a.m. and end November 19, 2013
at 4:00 p.m. The meeting is closed to the
public.
Dated: November 1, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of P01 Grant Application.
Date: November 21, 2013.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3An.18, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Robert Horowits, Ph.D.,
Senior Investigator, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3An.18,
Bethesda, MD 20892, 301–594–6904,
horowitr@mail.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the Government shutdown of October
2013.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: November 1, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26620 Filed 11–6–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2013–26625 Filed 11–6–13; 8:45 am]
BILLING CODE 4140–01–P
Center for Scientific Review; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institutes of Health
tkelley on DSK3SPTVN1PROD with NOTICES
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
VerDate Mar<15>2010
16:24 Nov 06, 2013
Jkt 232001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
66947
Chronic, Non-Communicable Diseases and
Disorder Across the Lifespan: Fogarty
International Research Training Award.
Date: November 15, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Silver Spring Hotel, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Rebecca Henry, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, 301–435–
1717, henryrr@mail.nih.gov.
This meeting notice is being published less
than 15 days in advance of the meeting due
to the Government shutdown of October
2013.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; SBIB
Pediatric and Fetal Applications.
Date: December 4, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: John Firrell, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5118,
MSC 7854, Bethesda, MD 20892, 301–435–
2598, firrellj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Dermatology, Rheumatology and
Inflammation.
Date: December 5, 2013.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Aruna K Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–435–
6809, beheraak@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Dermatology.
Date: December 5, 2013.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Aruna K Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–435–
6809, beheraak@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\07NON1.SGM
07NON1
66948
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
Dated: November 1, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26623 Filed 11–6–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Board of Scientific
Counselors, NIDA, October 22, 2013,
08:00 a.m. to October 22, 2013, 06:00
p.m., Intramural Research Program,
National Institute on Drug Abuse, NIH,
Johns Hopkins Bayview Campus,
Baltimore, MD, 21223 which was
published in the Federal Register on
September 10, 2013, 78, 175 FR2013–
21947.
The date of the meeting is changed to
December 19, 2013. The meeting is
closed to the public.
Dated: November 1, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–26622 Filed 11–6–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information on the Office
of Disease Prevention Draft Strategic
Plan for Fiscal Years 2014–2018
The purpose of this Request
for Information (RFI) is to seek broad
public input on the draft Strategic Plan
for Fiscal Years (FY) 2014–2018 for the
Office of Disease Prevention (ODP),
National Institutes of Health (NIH).
DATES: To ensure consideration,
responses must be received by
November 22, 2013.
ADDRESSES: Comments must be
submitted electronically using the webbased form available at https://
prevention.nih.gov/aboutus/strategic_
plan/rfi.aspx.
FOR FURTHER INFORMATION CONTACT:
Please direct all inquiries to Wilma
Peterman Cross, M.S.; Senior Public
Health Advisor, Office of Disease
Prevention,
National Institutes of Health; Phone:
301–496–1508; email: prevention@
mail.nih.gov.
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:24 Nov 06, 2013
Jkt 232001
The
mission of the ODP is to improve the
public health by increasing the scope,
quality, dissemination, and impact of
prevention research supported by the
NIH. The ODP fulfills this mission by
providing leadership for the
development, coordination, and
implementation of prevention research
in collaboration with NIH Institutes and
Centers and other partners. The Office is
responsible for advising the Director of
the NIH regarding prevention research
issues, actions, and activities. The
Office also provides overall guidance to
the NIH Institutes and Centers on
biomedical programs that seek to
improve the nation’s health through
research, training, knowledge
translation, and public education as
they relate to prevention.
Prevention research at the NIH
encompasses both primary and
secondary prevention. It includes
research designed to promote health; to
prevent onset of disease, disorders,
conditions, or injuries; and to detect and
prevent the progression of
asymptomatic disease. Prevention
research targets biology, individual
behavior, factors in the social and
physical environments, and health
services and informs and evaluates
health-related policies and regulations.
Prevention research includes studies
for:
• Identification and assessment of
risk and protective factors;
• Screening and identification of
individuals and groups at risk;
• Development and evaluation of
interventions to reduce risk;
• Translation, implementation, and
dissemination of effective preventive
interventions into practice; and
• Development of methods to support
prevention research.
Although established in 1986 in
response to a directive in the Health
Research Extension Act of 1985, the
Office has never had a formal strategic
plan. The ODP implemented an
extensive and inclusive process to
develop a strategic plan that would
outline the priorities for the Office over
the next five years and highlight the
ODP’s role in advancing prevention
research at the NIH. Feedback was
solicited from multiple stakeholder
communities including academia,
industry, health care professionals,
patient advocates and advocacy
organizations, scientific and
professional organizations, federal
agencies, and other interested members
of the public. Based on this feedback,
six strategic priorities were selected as
the framework for the plan. The
priorities represent the breadth of the
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
ODP portfolio and allow for emerging
areas of opportunity to be incorporated
into Office activities.
Information Requested
This RFI is intended to gather broad
public input on the ODP Draft Strategic
Plan for FY 2014–2018. While feedback
is welcome on any part of the draft
document, comments on the six
strategic priorities and related objectives
are encouraged. The ODP invites input
from prevention researchers in
academia and industry, health care
professionals, patient advocates and
advocacy organizations, scientific or
professional organizations, federal
agencies, and other interested members
of the public. Organizations are strongly
encouraged to submit a single response
that reflects the views of their
organization and membership as a
whole.
How To Submit a Response
To ensure consideration, responses
must be received by November 22, 2013,
and should be submitted electronically
using the web-based form available at
https://prevention.nih.gov/aboutus/
strategic_plan/rfi.aspx. The web form
will provide confirmation of response
submission, but respondents will not
receive individualized feedback. All
respondents are encouraged to sign up
for the ODP email list at https://
prevention.nih.gov/subscribe to receive
information related to Office activities,
including updates on the development
and release of the final strategic plan.
Responses to this RFI are voluntary
and may be submitted anonymously.
Please do not include any personally
identifiable or other information that
you do not wish to make public.
Proprietary, classified, confidential, or
sensitive information should not be
included in responses. Comments
submitted will be compiled for
discussion and incorporated into the
ODP strategic plan as appropriate. Any
personal identifiers (personal names,
email addresses, etc.) will be removed
when responses are compiled.
This RFI is for informational and
planning purposes only and is not a
solicitation for applications or an
obligation on the part of the U.S.
government to provide support for any
ideas identified in response to it. Please
note that the U.S. government will not
pay for the preparation of any
information submitted or for use of that
information.
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 78, Number 216 (Thursday, November 7, 2013)]
[Notices]
[Pages 66947-66948]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26623]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Chronic, Non-Communicable Diseases and Disorder
Across the Lifespan: Fogarty International Research Training Award.
Date: November 15, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Silver Spring Hotel, 8777 Georgia Avenue, Silver
Spring, MD 20910.
Contact Person: Rebecca Henry, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3222, MSC 7808, Bethesda, MD 20892, 301-435-
1717, henryrr@mail.nih.gov.
This meeting notice is being published less than 15 days in
advance of the meeting due to the Government shutdown of October
2013.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; SBIB Pediatric and Fetal Applications.
Date: December 4, 2013.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: John Firrell, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5118, MSC 7854, Bethesda, MD 20892, 301-435-
2598, firrellj@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Dermatology, Rheumatology and Inflammation.
Date: December 5, 2013.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Aruna K Behera, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD
20892, 301-435-6809, beheraak@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Dermatology.
Date: December 5, 2013.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Aruna K Behera, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD
20892, 301-435-6809, beheraak@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
[[Page 66948]]
Dated: November 1, 2013.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-26623 Filed 11-6-13; 8:45 am]
BILLING CODE 4140-01-P
